These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 1688724)

  • 1. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
    Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
    Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria.
    AUDITORE JV; HARTMANN RC; FLEXNER JM; BALCHUM OJ
    Arch Pathol; 1960 May; 69():534-43. PubMed ID: 13795052
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria.
    Sloand EM; Mainwaring L; Keyvanfar K; Chen J; Maciejewski J; Klein HG; Young NS
    Blood; 2004 Dec; 104(12):3782-8. PubMed ID: 15304386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect.
    AUDITORE JV; HARTMANN RC
    Am J Med; 1959 Sep; 27():401-10. PubMed ID: 13795054
    [No Abstract]   [Full Text] [Related]  

  • 5. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of in-vivo inhibition of acetylcholinesterase to affect erythrocyte life-span: the significance of the enzyme defect in paroxysmal nocturnal haemoglobinuria.
    METZ J; STEVENS K; VAN RENSBURG NJ; HART D
    Br J Haematol; 1961 Oct; 7():458-63. PubMed ID: 14473047
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
    Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
    Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of paroxysmal nocturnal hemoglobinuria in patients attended in Belém, Pará, Brazil.
    de Brito Junior LC; Cardoso Mdo S; Rocha EG; Anijar H; Cunha M; Saraiva JC
    Rev Bras Hematol Hemoter; 2011; 33(1):35-7. PubMed ID: 23284241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked glycosylation of dimeric acetylcholinesterase in erythrocytes is essential for enzyme maturation and membrane targeting.
    Luk WK; Chen VP; Choi RC; Tsim KW
    FEBS J; 2012 Sep; 279(17):3229-39. PubMed ID: 22805525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Erythrocyte Acetylcholinesterase in Health and Disease.
    Saldanha C
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28885588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase purification from human erythrocytes using magnetic nanoparticles containing procainamide.
    Mororó MCC; Mahnke LC; Assis CRD; da Silva RA; Cabrera MP; Bezerra RP; Carvalho Júnior LB; Alves MHME
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132094. PubMed ID: 38705318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D analysis of CROMER (DAF) and a new antigen CRAG.
    Floch A; Vege S; Hue-Roye K; Hamilton JR; Williams LA; Choate J; Lomas-Francis C; Westhoff CM
    Blood Transfus; 2022 Nov; 20(6):483-488. PubMed ID: 35175190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic and nonezymatic alterations of erythrocyte surface antigens.
    SPRINGER GF
    Bacteriol Rev; 1963 Jun; 27(2):191-227. PubMed ID: 13978549
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrocyte acetylcholinesterase as biomarker of pesticide exposure: new and forgotten insights.
    Assis CRD; Linhares AG; Cabrera MP; Oliveira VM; Silva KCC; Marcuschi M; Maciel Carvalho EVM; Bezerra RS; Carvalho LB
    Environ Sci Pollut Res Int; 2018 Jul; 25(19):18364-18376. PubMed ID: 29797194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases associated with complement deficiencies.
    Figueroa JE; Densen P
    Clin Microbiol Rev; 1991 Jul; 4(3):359-95. PubMed ID: 1889047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase and lymphocyte function-associated antigen 3 found on decay-accelerating factor-negative erythrocytes from some patients with paroxysmal nocturnal hemoglobinuria are lost during erythrocyte aging.
    Ueda E; Kinoshita T; Terasawa T; Shichishima T; Yawata Y; Inoue K; Kitani T
    Blood; 1990 Feb; 75(3):762-9. PubMed ID: 1688724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Inab phenotype: characterization of the membrane protein and complement regulatory defect.
    Telen MJ; Green AM
    Blood; 1989 Jul; 74(1):437-41. PubMed ID: 2473800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
    Fujioka S; Yamada T
    Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.